The trajectory of companies tied to flagship drugs like Viagra presents a challenging investment landscape . While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial https://phoenixhjjp363537.anchor-blog.com/21605962/sildenafil-and-its-maker-and-big-pharma-a-precarious-investment